Extra-esophageal GERD: Clinical dilemma of epidemiology versus clinical practice

Current Gastroenterology Reports

Volumn 9, Issue 3, 2007, Pages 195-202

  Long, Millie D ^b   Shaheen, Nicholas J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOMPERIDONE; ESOMEPRAZOLE; LANSOPRAZOLE; METHACHOLINE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; ROXATIDINE; TERBUTALINE;

ANTIREFLUX OPERATION; ASTHMA; CLINICAL FEATURE; CLINICAL TRIAL; COUGHING; DISEASE ASSOCIATION; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; ESOPHAGUS PH; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNGITIS; LARYNGOSCOPY; LIFESTYLE MODIFICATION; LOW DRUG DOSE; PATHOGENESIS; PREVALENCE; QUALITY OF LIFE; REVIEW; TREATMENT RESPONSE;

ASTHMA; COUGH; GASTROESOPHAGEAL REFLUX; HUMANS; LARYNGITIS; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 34249931105     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-007-0018-z     Document Type: Review

References (42)

1. Locke GR III, Talley NJ, Fett SL, et al.: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997, 112:1448-1456.
2. A Gallup Organization National Survey: Heartburn Across America. Princeton, NJ: The Gallup Organization Inc.; 1988.
3. Jaspersen D, Kulig M, Labenz J, et al.: Prevalence of extraoesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther 2003, 17:1515-1520.
4. Vaezi MF: Atypical manifestations of gastroesophageal reflux disease. MedGenMed 2005, 7:25.
5. Woolcock, AJ, Peat JK: Evidence for the increase in asthma worldwide. Ciba Found Symp 1997, 206:122-134.
6. el-Serag HB, Sonnenberg A: Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997, 113:755-760.
7. Vincent D, Cohen-Jonathan AM, Leport J, et al.: Gastrooesophageal reflux prevalence and relationship with bronchial reactivity in asthma. Eur Respir J 1997, 10:22SS-2259.
8. Harding SM, Guzzo MR, Richter JE: 24-h esophageal PH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest 1999, 115:654-659.
9. Nordenstedt H, Nilsson, M, johansson S, et al.: The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the Nord-Trondelag health survey. Chest 2006, 129:101-1056.
10. Kiljander TO, Laitinen JO: The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest 2004, 126(5):1490-1494.
11. Napierkowski J, Wong RK: Extraesophageal manifestations of GERD. Am J Med Sci 2003, 326:285-299.
12. Ford GA, Oliver PS, Prior JS, et al.: Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: a placebo-controlled cross-over study. Postgrad Med J 1994, 70:350-354.
13. Meier JH, McNally PR, Punja M, et al.: Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study. Dig Dis Sci 1994, 39:2127-2133.
14. Teichtahl H, Kronborg IJ, Yeomans ND, Robinson P: Adult asthma and gastro-oesophageal reflux: the effects of omeprazole therapy on asthma. Aust N Z J Med 1996, 26:671-676.
15. Levin TR, Sperling RM, McQuaid KR: Omeprazole improves peak expiratory flow fate and quality of life in asthmatics with gastroesophageal reflux. Am J Gastroenterol 1998, 93:1060-1063.
16. Boeree MJ, Peters FT, Postma DS, Kleibeuker JH: No effects of high-dose omeprazole in patients with severe airway hyper-responsiveness and (a)symptomatic gastro-oesophageal reflux. Eur Respir J 1998, 11:1070-1074.
17. Kiljander TO, Salomaa ER, Hietanen EK, Terho EO: Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole. Chest 1999, 11:1257-1264.
18. Jiang SP, Liang RY, Zeng ZY, et al.: Effects of antireflux treatment on bronchial hyper-responsiveness and lung function in asthmatic patients with gastroesophageal reflux disease. World J Gastroenterol 2003, 9:1123-1125.
19. Stordal K, Johannesdottir GB, Bentsen BS, et al.: Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease. Arch Dis Child 2005, 90:956-960.
20. Littner MR, Leung FW, Ballard ED II, et al.: Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 2005, 128:1128-1135.
21. Kiljander TO, Harding SM, Field SK, et al.: Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2006, 173:1091-1097.
22. Shimizu Y, Dobashi K, Kobayashi S, et al.: A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease. Tohoku J Exp Med 2006, 209:181-189.
23. Noordzij JP, Khidr A, Evans BA, et al.: Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001, 111:2147-2151.
24. El-Serag HB, Lee P, Buchner A, et al.: Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001, 96:979-983.
25. Eherer AJ, Habermann W, Hammer HF, et al.: Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol 2003, 38:462-467.
26. Irwin RS, Boulet LP, Cloutier MM, et al.: Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 1998, 114(2 Suppl):133S-181S.
27. Pratter MR, Bartter T, Akers S, DuBois J, et al.: An algorithmic approach to chronic cough. Ann Intern Med 1993, 119:977-983.
28. Smyrnios NA, Irwin RS, Curley FJ: Chronic cough with a history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest 1995, 108:991-997.
29. Smyrnios NA, Irwin RS, Curley FJ, French CL: From a prospective study of chronic cough: diagnostic and therapeutic aspects in older adults. Arch Intern Med 1998, 158:1222-1228.
30. Poe RH, Kallay MC: Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 2003, 123:679-684.
31. Harding SM, Richter JE: The role of gastroesophageal reflux in chronic cough and asthma. Chest 1997, 111:1389-1402.
32. Slusarcick AL, McCaig LF: National Hospital Ambulatory Medical Care Survey: 1998 outpatient department summary. Adv Data 2000, 317:1-23.
33. Ours TM, Kavuru MS, Schilz RJ, Richter JE: A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999, 94:3131-3138.
34. Kiljander TO, Salomaa ER, Hietanen EK, Terho EO: Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J 2000, 16:633-638.
35. Baldi F, Cappiello R, Cavoli C, et al.: Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. World J Gastroenterol 2006, 12:82-88.
36. Koufman JA: The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991, 101(4 Pt 2 Suppl. 53):1-78.
37. Wong RK, Hanson DG, Waring PJ, Shaw G: ENT manifestations of gastroesophageal reflux. Am J Gastroenterol 2000, 95(8 Suppl):S15-W22.
38. Steward DL, Wilson KM, Kelly DH, et al.: Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 2004, 131:342-350.
39. Vaezi MF, Richter JE, Stasney CR, et al.: Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006, 116:254-260.
40. Wo JM, Koopman J, Harrell SP, et al.: Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. Am J Gastroenterol 2006, 101:1972-1978.
41. Qadeer MA, Phillips CO, Lopez AR, et al.: Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2006, 101:2646-2654.
42. Scheutz F, Poulsen S: Determining causation in epidemiology. Community Dent Oral Epidemiol 1999, 27:161-170.